Your browser doesn't support javascript.
loading
Clinical characteristics and outcomes of patients requiring prolonged mechanical circulatory support after high-risk percutaneous coronary intervention.
Min, Sugi; Basir, Mir Babar; Lemor, Alejandro; Zhou, Zhipeng; Abu-Much, Arsalan; Redfors, Björn; Thompson, Julia B; Truesdell, Alexander G; Bharadwaj, Aditya S; Li, Yanru; Kaki, Amir; Brott, Brigitta C; Wohns, David H; Meraj, Perwaiz M; Daggubati, Ramesh; Grines, Cindy L; O'Neill, William W; Moses, Jeffrey W.
Afiliação
  • Min S; Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA.
  • Basir MB; Division of Cardiology, Henry Ford Hospital, Detroit, MI, USA.
  • Lemor A; Department of Cardiology, University of Mississippi Medical Center, Jackson, MS, USA.
  • Zhou Z; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
  • Abu-Much A; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
  • Redfors B; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
  • Thompson JB; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Truesdell AG; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
  • Bharadwaj AS; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
  • Li Y; Virginia Heart, Falls Church, VA, USA.
  • Kaki A; INOVA Heart and Vascular Institute, Falls Church, VA, USA.
  • Brott BC; Division of Cardiology, Loma Linda University Medical Center, Loma Linda, CA, USA.
  • Wohns DH; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.
  • Meraj PM; Interventional Cardiology Department, Ascension St. John Hospital and Center, Detroit, MI, USA.
  • Daggubati R; Division of Cardiovascular Disease, Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.
  • Grines CL; Spectrum Health, Frederik Meijer Heart and Vascular Institute, Grand Rapids, MI, USA.
  • O'Neill WW; Department of Cardiology, Zucker School of Medicine, Northwell Health, Manhasset, New York, NY, USA.
  • Moses JW; Division of Cardiology, West Virginia University, Morgantown, WV, USA.
EuroIntervention ; 20(2): e135-e145, 2024 Jan 15.
Article em En | MEDLINE | ID: mdl-38224254
ABSTRACT

BACKGROUND:

There are limited data on the clinical characteristics and outcomes of patients who require prolonged mechanical circulatory support (MCS) after Impella-supported high-risk percutaneous coronary intervention (HR-PCI).

AIMS:

The aim of this study is to describe the contemporary clinical characteristics, outcomes, and predictors associated with prolonged MCS support after assisted HR-PCI.

METHODS:

Patients enrolled in the prospective, multicentre, clinical endpoint-adjudicated PROTECT III study who had undergone HR-PCI using Impella were evaluated. Patient and procedural characteristics and outcomes for those who received prolonged MCS beyond the duration of their index procedure were compared to those in whom MCS was successfully weaned and explanted at the conclusion of the index PCI.

RESULTS:

Among 1,155 patients who underwent HR-PCI with Impella between 2017 and 2020 and had sufficient data to confirm the duration of Impella support, 16.5% received prolonged MCS (mean duration 25.2±31.1 hours compared with 1.8±5.8 hours for those who only received intraprocedural MCS). Patients receiving prolonged support presented with more urgent indications (e.g., acute coronary syndromes [ACS], lower ejection fraction [EF], elevated baseline heart rate and lower systolic blood pressure). Use of the Impella CP, intraprocedural complications, periprocedural complications and in-hospital mortality were all more common amongst the prolonged MCS group. Prolonged MCS was associated with increased rates of major adverse cardiovascular and cerebrovascular events, cardiovascular death, and all-cause mortality at 90-day follow-up.

CONCLUSIONS:

Patients receiving prolonged MCS after Impella-supported HR-PCI presented with more ACS, reduced EF and less favourable haemodynamics. Additionally, they were more likely to experience intraprocedural and periprocedural complications as well as increased in-hospital and post-discharge mortality.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Coronariana Aguda / Intervenção Coronária Percutânea Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Coronariana Aguda / Intervenção Coronária Percutânea Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article